Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses

Evaluation of Long-term Safety and Performance of AcrySof IQ Vivity Extended Vision and AcrySof IQ Vivity Toric Extended Vision Intraocular Lenses

The purpose of this post-market study is to describe the long-term safety and performance of AcrySof IQ Vivity and AcrySof IQ Vivity Toric intraocular lens (IOL) models in a real-world setting through routine clinical practice.

This study includes a retrospective chart review to obtain preoperative, operative, and post-operative data, and one prospective visit to collect key long-term safety and performance endpoints in a sample of subjects commercially implanted with the specified IOLs for 3 to 5 years in the real world.

This study will be conducted in the US and in Spain.

Key Inclusion Criteria:

• 22 years old or older at Visit 1.
• Able to understand and sign an approved informed consent form.
• Implantation of AcrySof IQ Vivity and/or Vivity Toric IOL models in both eyes for 3 to 5 years prior to enrollment.
• Documented medical history and required pre-operative baseline information available for retrospective data collection.
• Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria:

• Corneal refractive surgery after AcrySof Vivity or AcrySof Vivity Toric IOL implantation.
• Pregnant or nursing at the time of enrollment.
• Childbirth after IOL implantation.
• Other protocol-specified exclusion criteria may apply.